CDKN2A and cancer: Gene expression analysis performed using the TCGA database revealed that MDM2 and p16INK4a gene expression levels differ among patients with cancers, including those with glioblastoma multiforme; it is not known whether the regulatory regions of these genes have polymorphisms.